Immortalized Rat Hepatic Stellate Cells (CFSC-8B)

Cat.No.: CSC-I2672Z

Culture Properties: Adherent

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-I2672Z
Description
The CFSC-8B cell line is an immortalized hepatic stellate cell line derived from the liver of a rat with CCl₄-induced cirrhosis. These cells display typical stellate morphology, contain abundant lipid droplets and Golgi apparatus, and express key cytokines and receptors—including TGF-β, PDGF, and HGF—making them a relevant model for studying hepatic fibrosis, stellate cell activation, and liver disease mechanisms in vitro.
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Recommended Medium
SuperCult® Immortalized Rat Hepatic Stellate Cell Medium
Freezing Medium
Complete medium supplemented with 10% (v/v) DMSO
Culture Properties
Adherent
Quality Control
free from contaminations (bacteria incl. mycoplasma, fungi, HIV, HAV, HBV, HCV, Parvo-B19) and cross-contaminations
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments. Note: Never can cells be kept at -20°C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

The CFSC-8B cell line is an immortalized rat hepatic stellate cell (HSC) line derived from the liver of a rat with carbon tetrachloride (CCl₄)-induced cirrhosis, first established in 1991. Like other HSCs, these perisinusoidal cells reside in the space of Disse and play a central role in maintaining the hepatic microenvironment, primarily storing vitamin A in their lipid droplets during quiescence. In response to chronic liver injury (or standard culture on plastic), HSCs activate and transdifferentiate into a myofibroblast-like state capable of producing and secreting large quantities of extracellular matrix (ECM) compounds, notably type I collagen, which are the hallmark of hepatic fibrosis.

The CFSC-8B cell line exhibits a proliferating myofibroblast-like phenotype expressing key markers and cytokines associated with fibrogenesis. The cells express α-smooth muscle actin (α-SMA), desmin, glial fibrillary acidic protein (GFAP), collagens (types I and III), and soluble mediators including transforming growth factor-beta (TGF-β), platelet-derived growth factor (PDGF), and hepatocyte growth factor (HGF). They also contain abundant lipid droplets and Golgi apparatus, functional scavenger receptors (e.g., Stabilin‑1, LRP‑1), and respond to exogenous TGF‑β1 or acetaldehyde activation by further upregulating ECM production and proliferation.

As with other CFSC derivatives, the CFSC-8B genome exhibits extensive chromosome rearrangements and copy‑number variations (pseudotriploid karyotype), which should be considered when interpreting results concerning genetic stability. However, the major advantage of this line lies in its homogeneous, reproducible, and unlimited supply, overcoming the substantial hurdles of primary HSC isolation, which requires specialized equipment, trained personnel, and regulatory approval. Consequently, CFSC‑8B is an essential tool for high‑throughput antifibrotic drug screening, mechanistic studies of the TGF‑β1/Smad signaling axis in fibrosis, and investigations of liver regeneration and toxicology.

Insulin-like Growth Factor-I Reduces Collagen Production by Hepatic Stellate Cells

The liver is the major source of circulating insulin-like growth factor (IGF)-I. Serum IGF-I levels are decreased in cirrhotic patients depending on severity. IGF-I administration was shown to improve liver function in patients and animal models of liver cirrhosis. The effects of IGF-I on collagen accumulation by hepatic stellate cells (HSCs) and its mechanisms were studied.

A moderately activated HSC clone (CFSC-8B) was used to determine the effect of IGF-I administration on the collagen production system, including its degradation. The intracellular signaling system was also studied in the cells stimulated by IGF-I.

IGF-I treatment reduced total amounts of collagen deposition in a dose-related manner, while DNA synthesis was stimulated by IGF-I. IGF-I treatment did not affect transforming growth factor-beta levels and type I procollagen mRNA expression. Expression of matrix metalloproteinase (MMP)-2 and -9 was upregulated, and tissue inhibitor of metalloproteinase (TIMP)-1 expression was downregulated by IGF-I treatment. Rapamycin, an inhibitor of mammalian target of rapamycin (mTOR), suppressed phosphorylation of 70 kDa ribosomal protein S6 kinase and eukaryotic initiation factor 4E-binding protein 1, and abrogated IGF-I-induced increase in MMP-2 and -9 expression and decrease in TIMP-1 expression.

Effect of IGF-I Treatment on Collagen Deposition, Type I Alfa 1 Procollagen mRNA Expression, and TGF-Beta 1 Levels in the Culture Medium of cHSC.

Fig. 1. Effect of IGF-I addition on collagen deposition in the culture well, type I alfa 1 procollagen mRNA expression by CFSC-8B, and TGF-beta 1 levels in the medium (Nishikawa, Takako, et al., 2025).

Effect of Rapamycin on Expression of MMPs and TIMP-1 by CFSC-8B in the Presence of IGF-I.

Fig. 2. Effect of rapamycin on expression of MMPs and TIMP-1 by CFSC-8B in the presence of IGF-I (Nishikawa, Takako, et al., 2025).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products